Physician Assistant, Medical · Dallas, TX
NPI
1801041009
Since 2008
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3500 Oak Lawn Ave Ste 700
Dallas, TX, 75219
Phone (214) 521-0100
Medicare paid, 2024
$19K
2,396 services
Medicare patients, 2024
61
Average age 68
Drug cost, 2024
$4.4M
3,541 prescriptions
Company payments, 2025
$44K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Erin M Duhaime was code 99214 (office e&m - established), 72 times for 42 patients. In total Erin M Duhaime billed 2,396 services in 17 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 72 | 42 | $68.78 | $4,952 |
| 99232 Hospital E&M - Subsequent | Facility | 48 | 18 | $52.00 | $2,496 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 11 | 11 | $10.78 | $119 |
By year: 2022 $17K for 750 services; 2023 $11K for 582 services; 2024 $19K for 2,396 services.
Medicare prescription drug claims, 2024
In 2024, the drug Erin M Duhaime prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 170 prescriptions and refills. In total Erin M Duhaime wrote 3,541 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 170 | 178 | 23 | $698K |
| Dovato Dolutegravir Sodium/Lamivudine | 161 | 163 | 18 | $496K |
| Pifeltro Doravirine | 150 | 154 | 16 | $277K |
| Rosuvastatin Calcium Generic | 133 | 277 | 27 | $2,203 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 112 | 118 | 13 | $548K |
| Tivicay Dolutegravir Sodium | 91 | 105 | Under 11 | $229K |
| Alprazolam Generic | 81 | 91 | 11 | $744 |
| Descovy Emtricitabine/Tenofov Alafenam | 80 | 80 | Under 11 | $181K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 80 | 86 | 11 | $328K |
| Prezcobix Darunavir/Cobicistat | 80 | 80 | Under 11 | $198K |
| Doxycycline Hyclate Generic | 71 | 81 | 28 | $1,301 |
| Montelukast Sodium Generic | 70 | 104 | 15 | $378 |
| Trazodone Hcl Generic | 69 | 83 | Under 11 | $203 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 64 | 66 | 13 | $628 |
| Gabapentin Generic | 55 | 65 | 11 | $933 |
Brand drugs: - claims; generic drugs: 2,161 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Erin M Duhaime $44K ($44K in general payments such as food, travel and fees) from 19 companies. The largest payer was ViiV Healthcare Company with $34K.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 122 | $34K |
| Ferring Pharmaceuticals Inc. | 6 | $4,770 |
| Merck Sharp & Dohme LLC MRK | 15 | $3,686 |
| Gilead Sciences, Inc. GILD | 19 | $705 |
| Abbvie Inc. ABBV | 4 | $91.53 |
| Pfizer Inc. PFE | 4 | $85.82 |
| Theratechnologies Inc. THTX | 3 | $82.06 |
| EMD Serono, Inc. MRK.DE | 3 | $69.84 |
| Astellas Pharma US Inc 4503.T | 3 | $67.46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $59.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.